zerohedge.com / by Tyler Durden on 05/07/2015 12:51Three days ago, when looking at the unprecedented, record outflows from US equities (coupled with continued inflow into bond funds into what BofA’s Hans Mikkelsen would likely dub the Great Antirotation) we asked a simple question: “who is buying… no really“.Then yesterday, the spoofing algos were briefly spooked when Yellen, for the second […]
Janet Yellen has a crystal ball. And she sees trouble ahead…Yellen warned the investing public yesterday that stocks and bonds look risky in this ultra-low interest rate environment.But as you’ll see, Ms. Yellen’s crystal ball is notoriously foggy…and we might even make our money by ignoring her fortunetelling…“In a conversation with Christine Lagarde, the managing director of the International Monetary […]
At what point do you simply throw up your hands and “Alright, I’m in,” when it comes to buying into the incredible value in Regent Park?Every day, I scroll through new listings on MLS and I scoff at the low prices of condos on Cole and Sackville Streets, and I wonder when buyers will start flocking there in droves.I don’t […]
Yours truly can breath again having held his breath for probably longer than is safe, losing a few brain cells along the way. The enforced hypoxia experienced in my short bund holdings has been somewhat similar to that portrayed in movies where the hero manages to free himself from the sinking car and make it to the surface with only […]
The main theme of the year so far has been the volatility in the tech stocks, with may high fliers dropping overnight, including the biotech darlings of the last few years. The money seems to be rotating into the materials. The possible reversal of the US Dollar strength along with firming in the price of energy has contributed. I have […]
Biotech Stocks to Watch in May 2015
Biotech Stocks to Watch in May 2015
By profitconfidentialMay 5, 2015 6:53:59 AM PDT| 19 View(s) | Rating PrintEmailThe best biotech stocks to watch for in May 2015 are businesses that dominate their respective market, command a diverse drug pipeline, and have lots of profits to show for it.Profitability is crucial given that the NASDAQ […]
I borrowed this blog post from Michail Shadkin aka @EpicaCapital . I am posting it here so I can read it often. This a copy and paste and no editing has been done.6 types of relative strength/weakness very specific to MY intraday trading.Everybody has heard of relative strength and relative weakness, but what exactly is the strength/weakness relative […]
By Ben LevisohnRBC’s Michael Yee and team aren’t too worried about biotech stocks like Gilead Sciences (GILD), Celgene (CELG), and Biogen Idec (BIIB) despite the biotech sector’s big drop last week:
Biotech felt another volatile pullback (similar to March) in the last week of April, pulling back 9% in a week. Investors had their helmets on as we went right through […]
See original article:
Pharmaceutical industry regulation undermines …
See which stocks are being affected by Social Media
[…]
Original link:
May 2, 2015 – Weekend Market Comment
See which stocks are being affected by Social Media
[…]
